Home › Trial NCT05717699
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
- Trial IDNCT05717699
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorCapital Medical University
- Enrollment18
- Start date2023-01-04
- ConditionsOncolytic Virus · Diffuse Intrinsic Pontine Glioma · Adverse Drug Event
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.